The SpermCheck Fertility at-home sperm count test has landed retail distribution at Rite Aid drug stores nationwide.


SpermCheck Fertility, at-home sperm count test, ContraVac Inc., Rite Aid, drug stores, low sperm count, fertility issues, Ray Lopez, Dr. John Herr








































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks

SpermCheck expands distribution to Rite Aid

August 6th, 2014

CHARLOTTESVILLE, Va. – The SpermCheck Fertility at-home sperm count test has landed retail distribution at Rite Aid drug stores nationwide.

ContraVac Inc., doing business as SpermCheck, said Wednesday that the at-home screening test, with a suggested retail price of $39.99, is now available in the United States at Walgreens, Meijer and Rite Aid, as well as online.

The company added that with the success of SpermCheck Fertility in the United States, the product also has been launched in Boots retail pharmacies across the United Kingdom.

Approved by the Food and Drug Administration, SpermCheck Fertility determines with 98% accuracy if a man has normal or a low sperm count. Results are available in 10 minutes and can save the man a trip to the doctor's office or lab to provide a semen sample, the company noted.

The test was developed by Dr. John Herr, director of the Center for Research in Contraceptive and Reproductive Health at the University of Virginia, based on the discovery of a patented protein found in the head of mature sperm. Herr remains involved with SpermCheck as chairman of the board and chief scientific officer.

"SpermCheck Fertility is as simple to perform as a home pregnancy test," stated Ray Lopez, chief executive officer of SpermCheck. "With such high incidence of fertility issues, coupled with low incidence of male testing, we saw a great opportunity to provide couples with an at-home test that provides crucial information without the stigma."

The product is supported by a multi-pronged marketing campaign to reach consumers and influencers in the fertility community, SpermCheck said, adding that touch points include print, television, digital advertising, social media, freestanding inserts and in-store promotions.

More Supplier News Breaks >>
Advertisement